8.35
price down icon7.63%   -0.69
after-market After Hours: 8.35
loading
Lexeo Therapeutics Inc stock is traded at $8.35, with a volume of 2.99M. It is down -7.63% in the last 24 hours and up +26.13% over the past month. Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment.
See More
Previous Close:
$9.04
Open:
$8.7
24h Volume:
2.99M
Relative Volume:
3.26
Market Cap:
$450.91M
Revenue:
-
Net Income/Loss:
$-86.60M
P/E Ratio:
-2.948
EPS:
-2.8324
Net Cash Flow:
$-67.37M
1W Performance:
-17.16%
1M Performance:
+26.13%
6M Performance:
+79.96%
1Y Performance:
+1.33%
1-Day Range:
Value
$8.14
$9.0399
1-Week Range:
Value
$8.14
$10.38
52-Week Range:
Value
$1.45
$11.72

Lexeo Therapeutics Inc Stock (LXEO) Company Profile

Name
Name
Lexeo Therapeutics Inc
Name
Phone
(212) 547-9879
Name
Address
345 PARK AVENUE SOUTH, NEW YORK
Name
Employee
75
Name
Twitter
Name
Next Earnings Date
2025-03-24
Name
Latest SEC Filings
Name
LXEO's Discussions on Twitter

Compare LXEO with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
LXEO
Lexeo Therapeutics Inc
8.35 650.61M 0 -86.60M -67.37M -2.8324
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
421.67 109.22B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
628.00 67.50B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
423.47 57.35B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
831.48 50.87B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
182.77 39.72B 447.02M -1.18B -868.57M -6.1812

Lexeo Therapeutics Inc Stock (LXEO) Upgrades & Downgrades

Date Action Analyst Rating Change
Oct-15-25 Initiated Guggenheim Buy
Jul-31-25 Initiated Oppenheimer Outperform
Jun-13-24 Initiated Robert W. Baird Outperform
Jun-06-24 Initiated H.C. Wainwright Buy
Nov-28-23 Initiated Chardan Capital Markets Buy
Nov-28-23 Initiated JP Morgan Overweight
Nov-28-23 Initiated Leerink Partners Outperform
Nov-28-23 Initiated RBC Capital Mkts Outperform
Nov-28-23 Initiated Stifel Buy
View All

Lexeo Therapeutics Inc Stock (LXEO) Latest News

pulisher
07:10 AM

Is Lexeo Therapeutics Inc. meeting your algorithmic filter criteriaEarnings Trend Report & Long Hold Capital Preservation Plans - newser.com

07:10 AM
pulisher
04:27 AM

Using data models to predict Lexeo Therapeutics Inc. stock movementJuly 2025 Momentum & Low Drawdown Momentum Ideas - newser.com

04:27 AM
pulisher
03:22 AM

Using Python tools to backtest Lexeo Therapeutics Inc. strategiesQuarterly Earnings Report & Weekly Watchlist for Hot Stocks - newser.com

03:22 AM
pulisher
Nov 03, 2025

What to do if you’re stuck in Lexeo Therapeutics Inc.Market Risk Analysis & Weekly Watchlist of Top Performers - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Long term hold vs stop loss in Lexeo Therapeutics Inc.Gap Down & AI Driven Stock Reports - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

How Lexeo Therapeutics Inc. stock reacts to bond yieldsEarnings Miss & Smart Allocation Stock Reports - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Can Lexeo Therapeutics Inc. stock withstand economic slowdown2025 Top Gainers & Verified Short-Term Trading Plans - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Using Ichimoku Cloud for Lexeo Therapeutics Inc. technicalsPortfolio Value Report & Real-Time Market Trend Scan - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Multi asset correlation models including Lexeo Therapeutics Inc.July 2025 Levels & Real-Time Chart Breakout Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Is Lexeo Therapeutics (LXEO) One of Billionaire Daniel Sundheim’s Stock Picks with Huge Upside Potential - Yahoo! Finance Canada

Nov 03, 2025
pulisher
Nov 03, 2025

Will Lexeo Therapeutics Inc. price bounce be sustainableTrade Volume Summary & Verified Technical Trade Signals - newser.com

Nov 03, 2025
pulisher
Nov 02, 2025

Using data filters to optimize entry into Lexeo Therapeutics Inc.Portfolio Return Summary & Verified Momentum Stock Ideas - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Will Lexeo Therapeutics Inc. stock outperform Nasdaq index2025 EndofYear Setup & Safe Capital Allocation Plans - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Should you hold or exit Lexeo Therapeutics Inc. nowWeekly Volume Report & Risk Managed Investment Strategies - newser.com

Nov 02, 2025
pulisher
Nov 01, 2025

Why hedge funds are buying Lexeo Therapeutics Inc. stockEarnings Beat & High Conviction Buy Zone Picks - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Best data tools to analyze Lexeo Therapeutics Inc. stockGap Down & Weekly Return Optimization Plans - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Real time pattern detection on Lexeo Therapeutics Inc. stock2025 Growth vs Value & Fast Gain Stock Trading Tips - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Can Lexeo Therapeutics Inc. stock double in next 5 yearsJuly 2025 Opening Moves & Risk Controlled Swing Trade Alerts - newser.com

Nov 01, 2025
pulisher
Oct 31, 2025

RA CAPITAL MANAGEMENT, L.P. Acquires 5 Million Shares in Lexeo T - GuruFocus

Oct 31, 2025
pulisher
Oct 31, 2025

RA CAPITAL MANAGEMENT, L.P. Acquires 5 Million Shares in Lexeo Therapeutics Inc - GuruFocus

Oct 31, 2025
pulisher
Oct 31, 2025

Risk vs reward if holding onto Lexeo Therapeutics Inc.Market Activity Recap & Real-Time Stock Entry Alerts - newser.com

Oct 31, 2025
pulisher
Oct 29, 2025

Lexeo Therapeutics (LXEO) Price Target Increased by 19.77% to 21.29 - Nasdaq

Oct 29, 2025

Lexeo Therapeutics Inc Stock (LXEO) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Lexeo Therapeutics Inc Stock (LXEO) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Robertson Jenny
Chief Legal Officer
Oct 17 '25
Sale
8.94
3,526
31,530
68,930
Otero Jose Manuel
Chief Technical Officer
Oct 17 '25
Sale
8.94
2,115
18,913
64,197
Adler Eric
Chief Medical Officer
Oct 17 '25
Sale
8.94
3,382
30,242
73,261
Townsend Richard Nolan
Chief Executive Officer
Oct 17 '25
Sale
8.94
13,133
117,436
242,118
$37.84
price up icon 1.45%
$28.76
price up icon 0.17%
$102.92
price up icon 1.33%
$104.83
price up icon 0.84%
biotechnology ONC
$309.19
price down icon 0.86%
$182.77
price down icon 1.86%
Cap:     |  Volume (24h):